One potential therapeutic avenue for improving the lysis of brachyury-high tumor cells consists of tumor pretreatment with an inhibitor of the G2 checkpoint kinase, WEE1, which normally suppresses the activity of CDK1 via phosphorylation on Tyr-15. This evidence concerns the gene WEE1 and neoplasm.